Article info
PDFLung cancer
Original research
Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England
- Correspondence to Dr Aamir Khakwani, Division of Epidemiology & Public Health, University of Nottingham, Nottingham, UK; Aamir.Khakwani{at}nottingham.ac.uk
Citation
Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England
Publication history
- Received August 15, 2018
- Revised October 4, 2019
- Accepted October 9, 2019
- First published December 26, 2019.
Online issue publication
January 29, 2024
Article Versions
- Previous version (29 January 2024).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.